Biomet is now Zimmer Biomet

X

Consent Message

This website may set one or more cookies on your computer. For information about cookies in general, and the specific ones that may be set by this website, please read our Cookies Policy. For information about managing cookies, including how to prevent them from being set on your computer, visit the All About Cookies websiteContinued use of a Biomet website will be considered by us to be an expression of your consent to allow us to set one or more cookies on your computer.

Video Interview

Mr Mike Reed

For 16:9 format video

 

What benefits has the enhanced recovery programme brought to you and your practice?

I think the major benefits that we’ve had from enhanced recovery in our practice has been the reductions in complications, and that was really quite a surprise to us. When we first starting measuring the complications we were doing it because we were worried about increased risk, of complications, but in fact there’s been a really dramatic reduction in all sorts of complications including death in our series which clearly is a great advantage for us.

 

And why did you want implement an enhanced recovery programme?

If I’m honest the driver for us introducing enhanced recovery was not from me, but from our management who encouraged me on several occasions to go and see a programme that was active and live, and after some months and under some duress we took a group up there and that was really the time that we saw it in action and decided this is something we’ve got to do.

 

Why were management so keen to implement something like an enhanced recovery programme?

Well I think the driver for them, and at the time when we introduced it the only real knowledge was on the financial incentives which are probably £400 a day for an acute orthopaedic bed, and that’s you know, when you’re saving 3 days of length of stay, it’s a lot of money.

 

So, do you think it’s been mostly about cost saving? Or have there been other added benefits?

I think the initial driver, for this in our Trust probably was cost saving, but the benefits, the major benefits in fact have been complication reduction and that’s really where our focus is now.

 

How relevant is the collection of data about the programme in your hospital? And how can this best be done without additional workload?

I think the best way to collect data is to try and use an existing system that you have. And in the UK, at least certainly in England, we’re quite lucky where all the data is collected really for billing purposes and what we’ve done is we’ve managed to tap into that data to produce useful information for our own outcomes. And so this is essentially how we’ve shown the reduction in complications. Um, it’s clearly critical to have that data because firstly you have to prove that you’re not harming patients, it’s an added benefit if you’re helping them. But also you need to prove to your colleagues, perhaps the non-believers, that there is mileage in this and there is overall benefits. I mean, it’s really win-win because you’re saving money and you’re reducing complications, high patient satisfaction so for us it’s a no brainer.

 

Video Information

Interview with Mike Reed, Trauma and Orthopaedics Consultant

Related Videos

  Consultant Orthopaedic Surgeon
David Houlihan-Burne

  Consultant Anaesthetist
Nick Scott

 

More videos >>